Ambient
Showing 100451–100500 of 146505 results
-
Loxoprofen-d3
Molecular Formula : C15H15D3O3
-
Loxoprofen-d3
Molecular Formula : C15H15D3O3
-
Loxoprofen-d3
Molecular Formula : C15H15D3O3
-
Loxoprofen, Sodium Salt Dihydrate, NeuroPure
Loxoprofen, Sodium Salt Dihydrate, NeuroPure
-
Loxoprofen, Sodium Salt Dihydrate, NeuroPure
Loxoprofen, Sodium Salt Dihydrate, NeuroPure
-
Lp-PLA2 (10D46), mAb, Mouse
Lipoprotein-associated phospholipase A2 (LpPLA2) is an enzyme which participates in proinflammatory process. High concentration of LpPLA2 in serum indicates risk of heart attack and stroke. LpPLA2 is considered as specific coronary marker for diagnosing cardiovascular heart disease.
-
Lp-PLA2 (10D46), mAb, Mouse
Lipoprotein-associated phospholipase A2 (LpPLA2) is an enzyme which participates in proinflammatory process. High concentration of LpPLA2 in serum indicates risk of heart attack and stroke. LpPLA2 is considered as specific coronary marker for diagnosing cardiovascular heart disease.
-
Lp-PLA2 (10D46), mAb, Mouse
Lipoprotein-associated phospholipase A2 (LpPLA2) is an enzyme which participates in proinflammatory process. High concentration of LpPLA2 in serum indicates risk of heart attack and stroke. LpPLA2 is considered as specific coronary marker for diagnosing cardiovascular heart disease.
-
Lp-PLA2 (9C42), mAb, Mouse
Lipoprotein-associated phospholipase A2 (LpPLA2) is an enzyme which participates in proinflammatory process. High concentration of LpPLA2 in serum indicates risk of heart attack and stroke. LpPLA2 is considered as specific coronary marker for diagnosing cardiovascular heart disease.
-
Lp-PLA2 (9C42), mAb, Mouse
Lipoprotein-associated phospholipase A2 (LpPLA2) is an enzyme which participates in proinflammatory process. High concentration of LpPLA2 in serum indicates risk of heart attack and stroke. LpPLA2 is considered as specific coronary marker for diagnosing cardiovascular heart disease.
-
Lp-PLA2 (9C42), mAb, Mouse
Lipoprotein-associated phospholipase A2 (LpPLA2) is an enzyme which participates in proinflammatory process. High concentration of LpPLA2 in serum indicates risk of heart attack and stroke. LpPLA2 is considered as specific coronary marker for diagnosing cardiovascular heart disease.
-
LR3-IGF-I (Receptor Grade), Human
IGF-1 is a well-characterized basic peptide secreted by the liver that circulates in the blood. It has growth-regulating, insulin-like, mitogenic activities. IGF-1 is a growth factor that has a major, but not absolute, dependence on somatotropin. It is believed to be mainly active in adults in contrast to IGF-2, which is also a major fetal growth factor. Human Long R3 Insulin-like Growth Factor-1 (rhLR3IGF-1) contains an 83 amino acid analog of human IGF-I. Compared to the complete human IGF-I sequence, an addition of the rhLR3IGF-1 includes the substitution of an Arg for the Glu at position 3 (hence R3)and a13 amino acid extension peptide at the N-terminus. An enhanced potency is due to the markedly decreased binding of human Long-R3-IGF-I to IGF binding proteins which normally inhibit the biological actions of IGFs.
-
LR3-IGF-I (Receptor Grade), Human
IGF-1 is a well-characterized basic peptide secreted by the liver that circulates in the blood. It has growth-regulating, insulin-like, mitogenic activities. IGF-1 is a growth factor that has a major, but not absolute, dependence on somatotropin. It is believed to be mainly active in adults in contrast to IGF-2, which is also a major fetal growth factor. Human Long R3 Insulin-like Growth Factor-1 (rhLR3IGF-1) contains an 83 amino acid analog of human IGF-I. Compared to the complete human IGF-I sequence, an addition of the rhLR3IGF-1 includes the substitution of an Arg for the Glu at position 3 (hence R3)and a13 amino acid extension peptide at the N-terminus. An enhanced potency is due to the markedly decreased binding of human Long-R3-IGF-I to IGF binding proteins which normally inhibit the biological actions of IGFs.
-
LSM-Lymphocyte Separation Medium
Formulated for isolation of mononuclear cells from defibrinated or heparinized whole human blood.
-
LSM-Lymphocyte Separation Medium
Formulated for isolation of mononuclear cells from defibrinated or heparinized whole human blood.
-
Lubiprostone
Molecular Formula : C20 H32 F2 O5
-
Lubiprostone
Molecular Formula : C20 H32 F2 O5
-
Lubiprostone
Molecular Formula : C20 H32 F2 O5
-
Lubiprostone Impurity 2
Molecular Formula : C20 H30 F2 O4
-
Lubiprostone Impurity 2
Molecular Formula : C20 H30 F2 O4
-
Lubiprostone Impurity 2
Molecular Formula : C20 H30 F2 O4
-
Lubiprostone-d7
Molecular Formula : C20H25D7F2O5
-
Lubiprostone-d7
Molecular Formula : C20H25D7F2O5
-
Lubrol
Lubrol
-
Lubrol
Lubrol
-
Lucidenic Acid B
Molecular Formula : C27H38O7
-
Lucidenic Acid B
Molecular Formula : C27H38O7
-
Lucidenic Acid B
Molecular Formula : C27H38O7
-
Lucifer Yellow CH Dipotassium Salt (Technical Grade)
Molecular Formula : C13H9K2N5O9S2
-
Lucifer Yellow CH Dipotassium Salt (Technical Grade)
Molecular Formula : C13H9K2N5O9S2
-
Lucifer Yellow CH Dipotassium Salt (Technical Grade)
Molecular Formula : C13H9K2N5O9S2
-
Lufenuron
Molecular Formula : C17 H8 Cl2 F8 N2 O3
-
Lufenuron
Molecular Formula : C17 H8 Cl2 F8 N2 O3
-
Lufenuron
Molecular Formula : C17 H8 Cl2 F8 N2 O3
-
Lufenuron-D3
Molecular Formula : C17H5D3Cl2F8N2O3
-
Lufenuron-D3
Molecular Formula : C17H5D3Cl2F8N2O3
-
Lufenuron-D3
Molecular Formula : C17H5D3Cl2F8N2O3
-
Luliconazole
Molecular Formula : C14 H9 Cl2 N3 S2
-
Luliconazole
Molecular Formula : C14 H9 Cl2 N3 S2
-
Luliconazole
Molecular Formula : C14 H9 Cl2 N3 S2
-
Lumateperone
Molecular Formula : C24 H28 F N3 O
-
Lumateperone
Molecular Formula : C24 H28 F N3 O
-
Lumateperone
Molecular Formula : C24 H28 F N3 O
-
Lumazine
Molecular Formula : C6 H4 N4 O2
-
Lumazine
Molecular Formula : C6 H4 N4 O2
-
Lumazine
Molecular Formula : C6 H4 N4 O2
-
Lumefantrine
Molecular Formula : C30 H32 Cl3 N O
-
Lumefantrine
Molecular Formula : C30 H32 Cl3 N O
-
Lumefantrine
Molecular Formula : C30 H32 Cl3 N O
-
Lumefantrine-d18
Molecular Formula : C30H14D18Cl3NO